Solid Biosciences

Founded in 2013, Solid Biosciences is a precision genetic medicine company operating in the biotechnology research industry, focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases. Its pipeline includes SGT-003 for Duchenne muscular dystrophy, SGT-212 for Friedreich's ataxia, SGT-501 for catecholaminergic polymorphic ventricular tachycardia, and SGT-601 for TNNT2-mediated dilated cardiomyopathy and other fatal genetic cardiac diseases. Beyond its therapeutic candidates, the company develops innovative libraries of genetic regulators and other enabling technologies with the potential to significantly impact gene therapy delivery across the industry. Founded by individuals directly affected by Duchenne, Solid Biosciences is patient-focused and committed to uniting experts in science, technology, disease management, and care to improve the daily lives of those living with devastating rare diseases. The company employs more than 100 people and is headquartered at 500 Rutherford Ave, Third Floor, Boston, Massachusetts, in the United States.

• 

  Solid Biosciences

  9 days ago

  Senior director, clinical data systems & clinical programming

  hybrid, Cambridge, MA, United States

  $285k – $297k/yrFull TimeDirector

  Apply
• 

  Solid Biosciences

  9 days ago

  Senior director, biostatistics

  hybrid, Charlestown, MA, United States

  $290k – $308k/yrFull TimeDirector

  Apply
• 

  Solid Biosciences

  15 days ago

  Director, regulatory cmc

  onsite, Charlestown, MA, United States

  $230k – $260k/yrFull TimeDirector

  Apply
• 

  Solid Biosciences

  4 months ago

  Senior director, discovery & translational de

  onsite, Charlestown, MA, United States

  $260k – $305k/yrFull TimeDirector

  Apply
• S

  Solid Biosciences

  4 months ago

  Pr. associate scientist/scientist i, analytical development

  onsite, Charlestown, MA, United States

  $110k – $135k/yrFull TimeMiddle (2-4 years)

  Apply

Hiring activity at Solid Biosciences